BBR 3464 in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer That Cannot be Treated With Surgery

PHASE2UnknownINTERVENTIONAL
Timeline

Start Date

May 31, 2001

Conditions
Pancreatic Cancer
Interventions
DRUG

BBR 3464

Trial Locations (9)

22908

Cancer Center at the University of Virginia, Charlottesville

38119

Boston Baskin Cancer Group, University Tennessee Oncology/Hematology Group, Memphis

74104

Oklahoma Oncology Inc., Tulsa

94704

Alta Bates Comprehensive Cancer Center, Berkeley

85712-2254

Arizona Oncology Associates, Tucson

60611-3013

Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago

40536-0084

Albert B. Chandler Medical Center, University of Kentucky, Lexington

02215

Beth Israel Deaconess Medical Center, Boston

23298-0037

Massey Cancer Center, Richmond

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Theradex

INDUSTRY